journal article·2021-09-08Open access

Precision Wormlike Nanoadjuvant Governs Potency of Vaccination

Ziyang Sun, Dongdong Qiao, Yi Shi, Matthias Barz, Lixin Liu, Yongming Chen

Nano Letters· Volume 21· Issue 17

Abstract

It remains unclear how the precise length of one-dimensional nanovehicles influences the characters of vaccination. Here, a unimolecular nanovehicle with tailored size and aspect ratio (AR) is applied to deliver CpG oligodeoxynucleotide, a Toll-like receptor (TLR) 9 agonist, as an adjuvant of recombinant hepatitis B virus surface antigen (rHBsAg), for treating chronic hepatitis B (CHB). Cationic nanovehicles with fixed width (ca. 45 nm) but varied length (46 nm-180 nm), AR from 1 to 4, are prepared through controlled polymerization and are loaded with CpG by electrostatic interaction. We reveal that the nanoadjuvant with AR = 2 shows the highest retention in proximal lymph nodes. Importantly, it is more easily internalized into antigen-presenting cells and accumulates in the late endosome, where TLR9 is located. Such a nanoadjuvant exhibits the strongest immune response with rHBsAg to clear the hepatitis B virus in the CHB mouse model, showing that the AR of nanovehicles governs the efficiency of vaccination.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hepatitis B Virus Studies · Immunotherapy and Immune Responses · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China

Leiden Academic Center for Drug Research, Division of Biotherapeutics, Laboratory for Biotherapeutic Delivery, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands

Department Chemie, Johannes Gutenberg University, Duesbergweg 10-14, 55099 Mainz, Germany

State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

Funding

National Natural Science Foundation of China · Key Areas Research and Development Program of Guangzhou

References (40)

Show source-provided references
1. 10.1038/nm.340910.1038/nm.3409 ↗
2. 10.1016/j.immuni.2010.10.00210.1016/j.immuni.2010.10.002 ↗
3. 10.1038/s41578-019-0110-710.1038/s41578-019-0110-7 ↗
4. 10.1002/ar.2105110.1002/ar.21051 ↗
5. 10.1021/cb500079s10.1021/cb500079s ↗
6. 10.1146/annurev.immunol.20.100301.06484210.1146/annurev.immunol.20.100301.064842 ↗
7. 10.1007/BF0217208510.1007/BF02172085 ↗
8. 10.1002/wnan.135410.1002/wnan.1354 ↗
9. 10.1039/C8CS00028J10.1039/C8CS00028J ↗
10. 10.1016/j.jconrel.2017.02.03010.1016/j.jconrel.2017.02.030 ↗
11. 10.1038/nbt133210.1038/nbt1332 ↗
12. 10.1002/eji.20073798410.1002/eji.200737984 ↗
13. 10.1021/acs.chemrev.7b0019410.1021/acs.chemrev.7b00194 ↗
14. 10.1016/j.nano.2019.03.00210.1016/j.nano.2019.03.002 ↗
15. 10.1016/j.jconrel.2016.01.03010.1016/j.jconrel.2016.01.030 ↗
16. 10.1021/acsami.7b0581710.1021/acsami.7b05817 ↗
17. 10.1016/j.jconrel.2015.09.06910.1016/j.jconrel.2015.09.069 ↗
18. 10.1002/smll.20140236910.1002/smll.201402369 ↗
19. 10.1021/ma201495m10.1021/ma201495m ↗
20. Sun Z.Y. · Acta Polym. Sin. · 2020 · 51 · 609
21. 10.1016/j.biomaterials.2018.03.03210.1016/j.biomaterials.2018.03.032 ↗
22. 10.1021/ma981646310.1021/ma9816463 ↗
23. 10.1021/bm100971q10.1021/bm100971q ↗
24. 10.1021/acs.biomac.7b0117510.1021/acs.biomac.7b01175 ↗
25. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
26. 10.1021/acsnano.8b0834610.1021/acsnano.8b08346 ↗
27. 10.1016/j.jconrel.2017.08.00910.1016/j.jconrel.2017.08.009 ↗
28. 10.4049/jimmunol.080244210.4049/jimmunol.0802442 ↗
29. 10.1038/cmi.2013.4310.1038/cmi.2013.43 ↗
30. 10.7326/0003-4819-96-5-57510.7326/0003-4819-96-5-575 ↗
31. 10.1016/S0140-6736(14)60220-810.1016/S0140-6736(14)60220-8 ↗
32. 10.1016/S0140-6736(18)31865-810.1016/S0140-6736(18)31865-8 ↗
33. 10.1038/nrdp.2018.3510.1038/nrdp.2018.35 ↗
34. Tang H. · Drug News Perspect · 2001 · 14 · 325
35. 10.1007/978-981-13-9151-4_310.1007/978-981-13-9151-4_3 ↗
36. 10.1038/cmi.2015.6410.1038/cmi.2015.64 ↗
37. 10.1016/j.coviro.2017.03.01110.1016/j.coviro.2017.03.011 ↗
38. 10.1080/21645515.2016.127612510.1080/21645515.2016.1276125 ↗
39. 10.1016/j.vaccine.2009.09.10110.1016/j.vaccine.2009.09.101 ↗
40. 10.1016/j.addr.2019.09.00510.1016/j.addr.2019.09.005 ↗